PCI Biotech Holding
PCIB | OL
Overview
Corporate Details
- ISIN(s):
- NO0010405640
- LEI:
- 5967007LIEEXZXFIGG77
- Country:
- Norway
- Address:
- Ullernchausséen 64, 0379 OSLO
- Website:
- https://www.pcibiotech.no/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
PCI Biotech (OSE:PCIB) is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the true potential of a wide array of therapeutic modalities. The company is applying PCI to two distinct paradigms: - fimaVACC - Enhanced T-cell induction for therapeutic vaccination - fimaNAC - Nucleic acid therapeutics delivery Clinical proof-of-concept has been achieved in the lead programme fimaVacc, which applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines. The fimaNAc programme utilises the triggered endosomal release to provide effective intracellular delivery of nucleic acids, such as mRNA and siRNA therapeutics.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 09:45 |
AGM Report
PCI Biotech: Minutes of Annual General Meeting 2025
|
Norwegian | 449.8 KB | |
| 2025-05-22 09:45 |
Declaration of Voting Results & Voting Rights Announcements
PCI Biotech: Minutes of Annual General Meeting 2025
|
English | 866 bytes | |
| 2025-05-20 20:08 |
Declaration of Voting Results & Voting Rights Announcements
PCI BIotech: Disclosure of voting rights for Chair of the Board
|
English | 1.2 KB | |
| 2025-04-30 08:00 |
Report Publication Announcement
Notice of Annual General Meeting 2025
|
Norwegian | 188.6 KB | |
| 2025-04-30 08:00 |
Regulatory News Service
Notice of Annual General Meeting 2025
|
Norwegian | 146.9 KB | |
| 2025-04-30 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Notice of Annual General Meeting 2025
|
English | 167.8 KB | |
| 2025-04-30 08:00 |
Regulatory News Service
Notice of Annual General Meeting 2025
|
English | 208.0 KB | |
| 2025-04-30 08:00 |
General Meeting Notice
Notice of Annual General Meeting 2025
|
English | 977 bytes | |
| 2025-04-24 15:30 |
Annual Report
PCI Biotech Holding ASA: Annual Report 2024
|
English | 5.4 MB | |
| 2025-04-24 15:30 |
Annual Report
PCI Biotech Holding ASA: Annual Report 2024
|
English | 1.2 MB | |
| 2025-04-24 15:30 |
Report Publication Announcement
PCI Biotech Holding ASA: Annual Report 2024
|
English | 908 bytes | |
| 2025-02-27 06:00 |
Regulatory News Service
PCI Biotech full year 2024 interim results
|
English | 2.5 MB | |
| 2025-02-27 06:00 |
Regulatory News Service
PCI Biotech full year 2024 interim results
|
English | 978.4 KB | |
| 2025-02-27 06:00 |
Earnings Release
PCI Biotech full year 2024 interim results
|
English | 6.0 KB | |
| 2025-02-25 07:56 |
Earnings Release
PCI Biotech: Invitation to preliminary full-year 2024 results presentation
|
English | 2.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |